14.06.2013 Views

ANTI-NUTRITIONAL CONSTITUENT OF COLOCASIA ESCULENTA ...

ANTI-NUTRITIONAL CONSTITUENT OF COLOCASIA ESCULENTA ...

ANTI-NUTRITIONAL CONSTITUENT OF COLOCASIA ESCULENTA ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

a.-Amylase inhibitors could function as part of the defense mechanism in plants. In<br />

leguminous plants (Giri and Kachole, 1998; Melo et al., 1999) and cereals (Franco et al.,<br />

2000; Yamagata et al., 1998), the role of amylase inlnbitors as plant-defense proteins is<br />

pronounced and has received much focus (Gatehouse et al., 1986; Farmer and Ryan,<br />

1990). a-Amylases and proteinases are inactivated by these inlnbitors in the insect gut,<br />

thereby acting as insect anti-feedants. This interaction is believed to make plants less<br />

palatable. Indeed, it can even be lethal to insects. Thus, these inlnbitors present the plants<br />

with some selective advantages.<br />

Increasing natural defense mechanisms in plants can enhance agriculturaI activity and<br />

food safety by decreasing intensive use of pesticides (Huang et al., 1997; Chen et al.,<br />

1999). These inlnbitors, however, often show confined specificities: a given inhibitor<br />

may inhibit the major digestive enzymes ofone insect species, but not ofanother (Morton<br />

et al., 2000). This specificity has been widely investigated, with some inhibitors capable<br />

of acting against insect a-amylases or against mammalian enzymes only (Franco et aI.,<br />

2000). As a resuh, a-amylase inhibitors show potential for utilization in several fields,<br />

including protection ofcrops, obesity and treatment ofdiabetes (Tormo et aI., 2006).<br />

Diabetes mellitus is a metabolic disorder ofmultiple aetiology characterised by chronic<br />

hyperglycaemia with disturbance of carbohydrate, fat and protein metabolism resulting<br />

from defects in insulin secretion, insulin action or both (WHO, 1999). Glucose peaks<br />

occur after the intake of a meal in animals. a-Amylase inhibitors can reduce these peaks<br />

until the body is capable of processing the glucose. This is achieved by reducing the<br />

speed with which a-amylase can convert starch to simple sugars. Breuer (2003) held that<br />

this is especially important for diabetics who exhibit low insulin levels which hamper the<br />

prompt removal of extracellular glucose from the blood. Ali et al (2006) observed that<br />

reducing hyperglycaemia, using extracts of six selected Malaysian plants, after meals is<br />

one therapeutic approach which could be adopted in the treatement ofdiabetes.<br />

Clinical use of inhibitors of intraluminal a-amylase activity has appeal because, in<br />

theory, controlled reduction of starch digestion could influence carbohydrate uptake in<br />

123

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!